Crane (CR)
has always been a little different relative to its multi-industrial
peers, so I can't say that I'm all that surprised that this company's
recovery has followed a different trajectory. Not that this has done the
share price any harm - Crane shares are up about 100% over the past two
years, better than Parker-Hannifin (PH), Dover (DOV), Emerson (EMR), and many other peers that have seen sharper boom/bust cycles.
While
the recent Crane & Co. ("Crane Currency") acquisition should pay
off well over time, the near-term outlook for Crane is relatively tepid,
with the company expecting decent (but not market/segment-leading)
growth across its businesses in 2018 and not a lot of margin leverage.
Some investors may find that Crane shares still make sense on a relative
value basis, but I'm not inclined to chase these shares.
Read more here:
Crane Seeing A Choppier Recovery
No comments:
Post a Comment